Anticancer Therapies – News and Features

Speaking at a recent Technology Networks’ symposium, Dr. Jason Reeves explained how AI is changing the development of antibody–drug conjugates.

Scientists have developed a revolutionary AI "fingerprint" technology that can accurately show how cancer cells respond to new drugs, by simply observing changes to their shape.

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer, according to Oregon State University researchers.

New research from Mayo Clinic finds that the presence of a specific genetic mutation — KRAS circulating tumor DNA (ctDNA) — strongly indicates a higher risk of cancer spread and worse survival rates for patients with pancreatic ductal adenocarcinoma.

A study from St. Jude Children’s Research Hospital reveals that the protein VDAC2 acts as a “signal jammer” in tumors, preventing immune system communication. By removing VDAC2, tumors became more sensitive to immunotherapy.

IMFINZI^TM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed after platinum-based chemoradiation therapy.

Researchers are studying how exercise influences breast cancer progression. Their findings show that physical activity can lower estrogen levels, regulate metabolic markers, reduce chronic inflammation and boost immune responses.

Researchers demonstrate how breast cancer and its treatments contribute to accelerated aging in survivors. Breast cancer patients showed signs of faster biological aging compared to cancer-free individuals, with long-term lasting effects.

A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy.

Researchers find that tumor stem cells became less able to proliferate and invade tissues when gene editing blocked the production of the prion protein; the results suggest that the molecule could be a therapeutic target.